Invention Grant
US09095576B2 Pharmaceutical compositions comprising 4-[1-(2,3-dimethylphenyl)ethyl]-3H-imidazole derivatives for treating retinal diseases
有权
包含用于治疗视网膜疾病的4- [1-(2,3-二甲基苯基)乙基] -3H-咪唑衍生物的药物组合物
- Patent Title: Pharmaceutical compositions comprising 4-[1-(2,3-dimethylphenyl)ethyl]-3H-imidazole derivatives for treating retinal diseases
- Patent Title (中): 包含用于治疗视网膜疾病的4- [1-(2,3-二甲基苯基)乙基] -3H-咪唑衍生物的药物组合物
-
Application No.: US13680730Application Date: 2012-11-19
-
Publication No.: US09095576B2Publication Date: 2015-08-04
- Inventor: Mohammed I. Dibas , John E. Donello , Daniel W. Gil
- Applicant: Allergan, Inc.
- Applicant Address: US CA Irvine
- Assignee: Allergan, Inc.
- Current Assignee: Allergan, Inc.
- Current Assignee Address: US CA Irvine
- Agent Barbara C. Potts
- Main IPC: A01N43/58
- IPC: A01N43/58 ; A01N43/60 ; A61K31/50 ; A61K31/495 ; A61K31/4174
![Pharmaceutical compositions comprising 4-[1-(2,3-dimethylphenyl)ethyl]-3H-imidazole derivatives for treating retinal diseases](/abs-image/US/2015/08/04/US09095576B2/abs.jpg.150x150.jpg)
Abstract:
The present invention relates to pharmaceutical compositions, containing 4-[1-(2,3-dimethylphenyl)ethyl]-1H-imidazole, (S) 4-[1-(2,3-dimethylphenyl)ethyl]-1H-imidazole or (S) [3-(1-(1H-imidazol-4-yl)ethyl)-2-methylphenyl]methanol, their use as pharmaceuticals for the treatment of retinal diseases, for retinal neuroprotection and vision enhancement.
Public/Granted literature
Information query
IPC分类: